{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:20:15Z","timestamp":1791267615279,"version":"4.1.0"},"reference-count":167,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2909,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2710.2007.00846.x","type":"journal-article","created":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T15:14:34Z","timestamp":1279034074000},"page":"415-428","source":"Crossref","is-referenced-by-count":90,"title":["Augmentation strategies for treatment-resistant depression: a literature review"],"prefix":"10.1155","volume":"32","author":[{"given":"A. F.","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Castelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C. O.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,9,14]]},"reference":[{"issue":"Suppl. 4","key":"10.1111\/j.1365-2710.2007.00846.x-BIB1|cit1","first-page":"53","article-title":"Remission versus response: the new gold standard of antidepressant care","volume":"65","author":"Keller","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 13","key":"10.1111\/j.1365-2710.2007.00846.x-BIB2|cit2","first-page":"18","article-title":"Evaluating antidepressant therapies: remission as the optimal outcome","volume":"64","author":"Thase","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 6","key":"10.1111\/j.1365-2710.2007.00846.x-BIB3|cit3","first-page":"27","article-title":"Major depressive disorder: remission of associated symptoms","volume":"67","author":"Trivedi","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors","volume":"178","author":"Thase","year":"2001","journal-title":"British Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1176\/appi.ajp.159.3.469","article-title":"Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?","volume":"159","author":"Zimmerman","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4088\/JCP.v60n0403","article-title":"Residual symptoms in depressed patients who respond acutely to fluoxetine","volume":"60","author":"Nierenberg","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4088\/JCP.v66n1110","article-title":"Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine","volume":"66","author":"Nelson","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1017\/S0033291700033146","article-title":"Residual symptoms after partial remission: an important outcome in depression","volume":"25","author":"Paykel","year":"1995","journal-title":"Psychological Medicine"},{"issue":"Suppl. 6","key":"10.1111\/j.1365-2710.2007.00846.x-BIB10|cit10","first-page":"10","article-title":"Acute and maintenance treatment of chronic depression","volume":"62","author":"Dunner","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1176\/appi.ajp.157.9.1501","article-title":"Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?","volume":"157","author":"Judd","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1176\/appi.ps.56.8.1005","article-title":"Pharmacologic management of difficult-to-treat depression in clinical practice","volume":"56","author":"Fleck","year":"2005","journal-title":"Psychiatric Services"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1520-6394(1997)5:4<154::AID-DA2>3.0.CO;2-D","article-title":"Treatment-refractory depression: definitions and characteristics","volume":"5","author":"Berman","year":"1997","journal-title":"Depression and Anxiety"},{"issue":"Suppl. 13","key":"10.1111\/j.1365-2710.2007.00846.x-BIB14|cit14","first-page":"23","article-title":"When at first you don\u2019t succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 6","key":"10.1111\/j.1365-2710.2007.00846.x-BIB15|cit15","first-page":"16","article-title":"Treatment-resistant depression","volume":"67","author":"Souery","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archpsyc.1997.01830230043006","article-title":"Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations","volume":"54","author":"Thase","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","article-title":"Central monoamines and their role in major depression","volume":"28","author":"Elhwuegi","year":"2004","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.7326\/0003-4819-143-6-200509200-00006","article-title":"Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder","volume":"143","author":"Hansen","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15622970209150599","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder","volume":"3","author":"Bauer","year":"2002","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/070674370004500509","article-title":"Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians","volume":"45","author":"Mischoulon","year":"2000","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4088\/JCP.v61n0602","article-title":"Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current \u201cnext-step\u201d practices","volume":"61","author":"Fredman","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 15","key":"10.1111\/j.1365-2710.2007.00846.x-BIB23|cit23","first-page":"35","article-title":"Treatment of antidepressant nonresponders: augmentation or switch?","volume":"59","author":"Nelson","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 428","key":"10.1111\/j.1365-2710.2007.00846.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.2005.00676.x","article-title":"Potentiation strategies for treatment-resistant depression","volume":"112","author":"Ros","year":"2005","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000091771","article-title":"Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice","volume":"75","author":"Fava","year":"2006","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archpsyc.1983.01790110077013","article-title":"Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression","volume":"40","author":"Heninger","year":"1983","journal-title":"Archives of General Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/070674378603100506","article-title":"The benefit of lithium carbonate adjunct in refractory depression - fact or fiction?","volume":"31","author":"Kantor","year":"1986","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00004714-198804000-00007","article-title":"Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study","volume":"8","author":"Zusky","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2007-1014603","article-title":"Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study","volume":"22","author":"Schopf","year":"1989","journal-title":"Pharmacopsychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00004850-199004000-00004","article-title":"Lithium as an adjunct in the treatment of major depression","volume":"5","author":"Browne","year":"1990","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archpsyc.1993.01820170065008","article-title":"A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression","volume":"50","author":"Joffe","year":"1993","journal-title":"Archives of General Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB32|cit32","first-page":"634","article-title":"Lithium augmentation therapy in tricyclic-resistant depression","volume":"162","author":"Stein","year":"1993","journal-title":"A controlled trial using lithium in low and normal doses. British Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1192\/bjp.166.1.80","article-title":"Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine","volume":"166","author":"Katona","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00004714-199608000-00006","article-title":"A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation","volume":"16","author":"Baumann","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-0327(02)00086-1","article-title":"Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150\u2003mg\/day) plus lithium carbonate (750\u2003mg\/day) versus clomipramine (150\u2003mg\/day) plus placebo in the treatment of unipolar major depression","volume":"76","author":"Januel","year":"2003","journal-title":"Journal of Affective Disorders"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1176\/appi.ajp.157.9.1429","article-title":"Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression","volume":"157","author":"Bauer","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00004714-199910000-00006","article-title":"Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies","volume":"19","author":"Bauer","year":"1999","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1176\/ajp.151.9.1372","article-title":"Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study","volume":"151","author":"Fava","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004714-200208000-00008","article-title":"Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine","volume":"22","author":"Fava","year":"2002","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1192\/bjp.157.5.718","article-title":"The efficacy of lithium in prophylaxis of unipolar depression Evidence from its discontinuation","volume":"157","author":"Souza","year":"1990","journal-title":"British Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00004714-199702000-00005","article-title":"Gradual discontinuation of lithium augmentation in elderly patients with unipolar depression","volume":"17","author":"Hardy","year":"1997","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/gps.453","article-title":"Discontinuation of lithium augmentation in an elderly cohort","volume":"16","author":"Fahy","year":"2001","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.2174\/138161206777947650","article-title":"Efficacy and mechanisms of action of lithium augmentation in refractory major depression","volume":"12","author":"Bschor","year":"2006","journal-title":"Current Pharmaceutical Design"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1192\/bjp.159.3.341","article-title":"Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome","volume":"159","author":"Cowen","year":"1991","journal-title":"British Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0893-133X(02)00323-8","article-title":"Lithium augmentation increases the ACTH and cortisol response in the combined DEX\/CRH test in unipolar major depression","volume":"27","author":"Bschor","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/da.10078","article-title":"Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression","volume":"17","author":"Bschor","year":"2003","journal-title":"Depression and Anxiety"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1590\/S0004-27302004000100016","article-title":"Subclinical thyroid disease: subclinical hypothyroidism and hyperthyroidism","volume":"48","author":"Romaldini","year":"2004","journal-title":"Arquivos Brasileiros de Endocrinolologia e Metabolologia"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archpsyc.1996.01830090090013","article-title":"Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis","volume":"53","author":"Aronson","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S146114570200322X","article-title":"Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation","volume":"6","author":"Agid","year":"2003","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4088\/JCP.v66n0812","article-title":"An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder","volume":"66","author":"Iosifescu","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jad.2006.01.013","article-title":"T3 augmentation of SSRI resistant depression","volume":"91","author":"Abraham","year":"2006","journal-title":"Journal of Affective Disorders"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1176\/appi.ajp.158.10.1617","article-title":"Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature","volume":"158","author":"Altshuler","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0165-1781(90)90029-5","article-title":"A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants","volume":"32","author":"Joffe","year":"1990","journal-title":"Psychiatry Research"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1461145700001875","article-title":"Pharmacological mechanisms of T3 augmentation of antidepressant action","volume":"3","author":"Newman","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/138945006775515482","article-title":"Basic mechanisms of augmentation of antidepressant effects with thyroid hormone","volume":"7","author":"Lifschytz","year":"2006","journal-title":"Current Drug Targets"},{"issue":"Suppl. 4","key":"10.1111\/j.1365-2710.2007.00846.x-BIB57|cit57","first-page":"4","article-title":"Early onset of antidepressant action: impact on primary care","volume":"62","author":"Culpepper","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role for 5-HT1A agonists in the treatment of depression?","volume":"53","author":"Blier","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB59|cit59","first-page":"269","article-title":"An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression","volume":"54","author":"Joffe","year":"1993","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB60|cit60","first-page":"217","article-title":"Possible augmentation of antidepressant response by buspirone","volume":"52","author":"Jacobsen","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00004714-199812000-00009","article-title":"Buspirone augmentation of antidepressant therapy","volume":"18","author":"Dimitriou","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4088\/JCP.v59n1204","article-title":"A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression","volume":"59","author":"Landen","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4088\/JCP.v62n0608","article-title":"Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study","volume":"62","author":"Appelberg","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0327(02)00404-4","article-title":"Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials","volume":"79","author":"Ballesteros","year":"2004","journal-title":"Journal of Affective Disorders"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0006-3223(00)00993-8","article-title":"Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies","volume":"48","author":"Martinez","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4088\/JCP.v65n0215","article-title":"Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial","volume":"65","author":"Perry","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1192\/bjp.147.1.16","article-title":"L-5HTP in depression resistant to re-uptake inhibitors. An open comparative study with tranylcypromine","volume":"147","author":"Nolen","year":"1985","journal-title":"British Journal of Psychiatry"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2710.2007.00846.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000285154","article-title":"Treatment for therapy-resistant depression","volume":"19","author":"Kielholz","year":"1986","journal-title":"Psychopathology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1192\/bjp.151.2.213","article-title":"Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies","volume":"151","author":"Hale","year":"1987","journal-title":"British Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1600-0447.1988.tb06403.x","article-title":"Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine","volume":"78","author":"Nolen","year":"1988","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-0327(79)90002-8","article-title":"Bromocriptine in affective disorders. A pilot study","volume":"1","author":"Colonna","year":"1979","journal-title":"Journal of Affective Disorders"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(84)91359-X","article-title":"Response to bromocriptine distinguishes bipolar from unipolar depression","volume":"1","author":"Silverstone","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB73|cit73","first-page":"207","article-title":"An antidepressant adjuvant for mood disorders?","volume":"29","author":"Bouckoms","year":"1993","journal-title":"Psychopharmacological Bulletin"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004850-200303000-00005","article-title":"Amantadine as augmentation therapy in the management of treatment-resistant depression","volume":"18","author":"Stryjer","year":"2003","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB75|cit75","first-page":"735","article-title":"Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression","volume":"56","author":"Rogoz","year":"2004","journal-title":"Polish Journal of Pharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10401230009147102","article-title":"Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review","volume":"12","author":"Sporn","year":"2000","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1034\/j.1399-5618.2002.01171.x","article-title":"Pramipexole in treatment-resistant depression: a 16-week naturalistic study","volume":"4","author":"Lattanzi","year":"2002","journal-title":"Bipolar Disorders"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2001-15872","article-title":"Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series","volume":"34","author":"Perugi","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004714-199104000-00010","article-title":"CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression","volume":"11","author":"Fawcett","year":"1991","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB80|cit80","first-page":"206","article-title":"Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression","volume":"46","author":"Feighner","year":"1985","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1176\/ajp.146.6.803b","article-title":"Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine","volume":"146","author":"Linet","year":"1989","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/(SICI)1520-6394(1998)7:2<89::AID-DA8>3.0.CO;2-0","article-title":"Psychostimulant augmentation of second generation antidepressants: a case series","volume":"7","author":"Masand","year":"1998","journal-title":"Depression and Anxiety"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004850-199100620-00003","article-title":"Combination of fluoxetine with pemoline in the treatment of major depressive disorder","volume":"6","author":"Metz","year":"1991","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB84|cit84","first-page":"72","article-title":"Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series","volume":"57","author":"Stoll","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1176\/ajp.127.12.1619","article-title":"A potential clinical use for methylphenidate with tricyclic antidepressants","volume":"127","author":"Wharton","year":"1971","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/070674379504000707","article-title":"Experimental and clinical pharmacology of psychostimulants","volume":"40","author":"Bourin","year":"1995","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4088\/JCP.v61n0510","article-title":"Modafinil augmentation of antidepressant treatment in depression","volume":"61","author":"Menza","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00004714-200304000-00017","article-title":"An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy","volume":"23","author":"Markovitz","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.jcp.0000104910.75206.b9","article-title":"A prospective trial of modafinil as an adjunctive treatment of major depression","volume":"24","author":"DeBattista","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/08039480510023025","article-title":"Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92)","volume":"59","author":"Rasmussen","year":"2005","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.v65n0318","article-title":"Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue","volume":"65","author":"Ninan","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4088\/JCP.v64n0911","article-title":"Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study","volume":"64","author":"DeBattista","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4088\/JCP.v66n0112","article-title":"A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness","volume":"66","author":"Fava","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S1092852900010622","article-title":"Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study","volume":"11","author":"Thase","year":"2006","journal-title":"CNS Spectrums"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4088\/JCP.v60n0410","article-title":"Risperidone augmentation of selective serotonin reuptake inhibitors in major depression","volume":"60","author":"Ostroff","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1176\/appi.ajp.158.1.131","article-title":"A novel augmentation strategy for treating resistant major depression","volume":"158","author":"Shelton","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/da.10137","article-title":"Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors","volume":"19","author":"Adson","year":"2004","journal-title":"Depression and Anxiety"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004850-200501000-00002","article-title":"Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients","volume":"20","author":"Worthington","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.4088\/JCP.v66n1017","article-title":"Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder","volume":"66","author":"Papakostas","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4088\/JCP.v65n0212","article-title":"Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder","volume":"65","author":"Papakostas","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB101|cit101","volume-title":"Adjunctive ziprasidone in treatment-resident depression: a pilot study","author":"Dunner","year":"2003"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2710.2007.00846.x-BIB102|cit102","first-page":"S159","volume-title":"Neuropsychopharmacology","volume":"29","author":"Nemeroff","year":"2004"},{"issue":"Suppl. 3","key":"10.1111\/j.1365-2710.2007.00846.x-BIB103|cit103","first-page":"S182","article-title":"Meta-analysis of olanzapine-fluoxetine use in treatment-resistant depression","volume":"12","author":"Dube","year":"2002","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"Suppl. 8","key":"10.1111\/j.1365-2710.2007.00846.x-BIB104|cit104","first-page":"30","article-title":"Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety","volume":"66","author":"Blier","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jnr.10281","article-title":"Atypical neuroleptics stimulate neurogenesis in adult rat brain","volume":"69","author":"Wakade","year":"2002","journal-title":"Journal of Neuroscience Research"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.biopsych.2004.07.008","article-title":"Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat","volume":"56","author":"Kodama","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"Journal of Neuroscience"},{"issue":"Suppl. 9","key":"10.1111\/j.1365-2710.2007.00846.x-BIB108|cit108","first-page":"25","article-title":"Pathophysiology of antipsychotic drug-induced movement disorders","volume":"65","author":"Casey","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 18","key":"10.1111\/j.1365-2710.2007.00846.x-BIB109|cit109","first-page":"36","article-title":"Abnormalities of glucose metabolism associated with atypical antipsychotic drugs","volume":"65","author":"Newcomer","year":"2004","journal-title":"Journal of Clinical"},{"issue":"Suppl. 14","key":"10.1111\/j.1365-2710.2007.00846.x-BIB110|cit110","first-page":"1","article-title":"Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization","volume":"10","author":"Masand","year":"2005","journal-title":"CNS Spectrums"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0165-0327(93)90103-Q","article-title":"Hypnotics as concurrent medication in depression. A placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant","volume":"28","author":"Nolen","year":"1993","journal-title":"Journal of Affective Disorders"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-0327(01)00352-4","article-title":"Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?","volume":"70","author":"Smith","year":"2002","journal-title":"Journal of Affective Disorders"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4088\/JCP.v60n1005","article-title":"Zolpidem for persistent insomnia in SSRI-treated depressed patients","volume":"60","author":"Asnis","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.biopsych.2006.01.016","article-title":"Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder","volume":"59","author":"Fava","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1081\/JA-100104489","article-title":"Use and misuse of benzodiazepines in Brazil: a review","volume":"36","author":"Kapczinski","year":"2001","journal-title":"Substance Use and Misuse"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1176\/ajp.144.9.1246","article-title":"Misuse and abuse of benzodiazepines","volume":"144","author":"Ciccone","year":"1987","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00002018-200326040-00004","article-title":"New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon","volume":"26","author":"Terzano","year":"2003","journal-title":"Drug Safety"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11910-003-0074-1","article-title":"Hypnotics: an update","volume":"3","author":"Roehrs","year":"2003","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004714-199912002-00002","article-title":"Effectiveness and safety of benzodiazepines","volume":"19","author":"Moller","year":"1999","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004850-199603000-00008","article-title":"Carbamazepine augmentation therapy in three patients with trazodone-resistant unipolar depression","volume":"11","author":"Otani","year":"1996","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/10401239309148973","article-title":"Identification of treatment-resistant depressives who respond favorably to carbamazepine","volume":"5","author":"Varney","year":"1993","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0006-3223(92)90041-W","article-title":"Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression","volume":"32","author":"De la Fuente","year":"1992","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jad.2004.01.006","article-title":"Mood stabilizer augmentation in apparently \u201cunipolar\u201d MDD: predictors of response in the naturalistic French national EPIDEP study","volume":"84","author":"Hantouche","year":"2005","journal-title":"Journal of Affective Disorders"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4088\/JCP.v63n0411","article-title":"Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study","volume":"63","author":"Normann","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4088\/JCP.v64n0407","article-title":"A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes","volume":"64","author":"Barbosa","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0165-0327(00)00187-7","article-title":"Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review","volume":"63","author":"Yasmin","year":"2001","journal-title":"Journal of Affective Disorders"},{"issue":"Suppl. 4","key":"10.1111\/j.1365-2710.2007.00846.x-BIB128|cit128","first-page":"15","article-title":"Basic psychopharmacology of antidepressants, part 2: Estrogen as an adjunct to antidepressant treatment","volume":"59","author":"Stahl","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 18","key":"10.1111\/j.1365-2710.2007.00846.x-BIB129|cit129","first-page":"8","article-title":"Special issues related to the treatment of depression in women","volume":"64","author":"Yonkers","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0006-3223(85)90031-9","article-title":"Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives","volume":"20","author":"Shapira","year":"1985","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB131|cit131","first-page":"705","article-title":"Addition of estrogen to imipramine in female-resistant depressives","volume":"21","author":"Zohar","year":"1985","journal-title":"Psychopharmacoogical Bulletin"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-0327(98)00203-1","article-title":"Fluoxetine efficacy in menopausal women with and without estrogen replacement","volume":"55","author":"Amsterdam","year":"1999","journal-title":"Journal of Affective Disorders"},{"issue":"Suppl. 7","key":"10.1111\/j.1365-2710.2007.00846.x-BIB133|cit133","first-page":"45","article-title":"Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women","volume":"63","author":"Rasgon","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00019442-199700520-00002","article-title":"Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group","volume":"5","author":"Schneider","year":"1997","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB135|cit135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00019442-200111000-00007","article-title":"Estrogen replacement therapy and antidepressant response to sertraline in older depressed women","volume":"9","author":"Schneider","year":"2001","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB136|cit136","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.156.4.646","article-title":"Double-blind treatment of major depression with dehydroepiandrosterone","volume":"156","author":"Wolkowitz","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1176\/appi.ajp.160.1.105","article-title":"Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial","volume":"160","author":"Pope","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0891988704271767","article-title":"Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy","volume":"18","author":"Orengo","year":"2005","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB139|cit139","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.jcp.0000185424.23515.e5","article-title":"Intramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trial","volume":"25","author":"Seidman","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s007020050200","article-title":"Inositol addition does not improve depression in SSRI treatment failures","volume":"106","author":"Nemets","year":"1999","journal-title":"Journal of Neural Transmission"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1176\/ajp.156.12.2017","article-title":"Treatment augmentation with opiates in severe and refractory major depression","volume":"156","author":"Stoll","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB142|cit142","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004714-199502000-00008","article-title":"Buprenorphine treatment of refractory depression","volume":"15","author":"Bodkin","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB143|cit143","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0899-9007(99)00115-X","article-title":"Primer in folic acid: folates and neuropsychiatry","volume":"15","author":"Abalan","year":"1999","journal-title":"Nutrition"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0899-9007(00)00327-0","article-title":"Nutrition and depression: focus on folate","volume":"16","author":"Alpert","year":"2000","journal-title":"Nutrition"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230209147396","article-title":"Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression","volume":"14","author":"Alpert","year":"2002","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB146|cit146","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-0327(00)00153-1","article-title":"Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial","volume":"60","author":"Coppen","year":"2000","journal-title":"Journal of Affective Disorders"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB147|cit147","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1600-0447.1990.tb05476.x","article-title":"The antidepressant potential of oral S-adenosyl-l-methionine","volume":"81","author":"Rosenbaum","year":"1990","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB148|cit148","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.jcp.0000145339.45794.cd","article-title":"S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine","volume":"24","author":"Alpert","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB149|cit149","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0165-1781(92)90029-3","article-title":"Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine","volume":"44","author":"Berlanga","year":"1992","journal-title":"Psychiatry Research"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB150|cit150","first-page":"121","article-title":"Response to steroid suppression in major depression resistant to antidepressant therapy","volume":"11","author":"Murphy","year":"1991","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB151|cit151","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0306-4530(94)90064-7","article-title":"Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids","volume":"19","author":"Wolkowitz","year":"1994","journal-title":"Psychoneuroendocrinology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB152|cit152","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0006-3223(94)00245-X","article-title":"Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report","volume":"37","author":"Anand","year":"1995","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB153|cit153","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0006-3223(94)00150-2","article-title":"The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment","volume":"37","author":"Ghadirian","year":"1995","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB154|cit154","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0165-0327(94)00082-K","article-title":"Treatment of major depression with metyrapone and hydrocortisone","volume":"33","author":"O\u2019Dwyer","year":"1995","journal-title":"Journal of Affective Disorders"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB155|cit155","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0006-3223(98)00267-4","article-title":"Antiglucocorticoid treatment of depression: double-blind ketoconazole","volume":"45","author":"Wolkowitz","year":"1999a","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB156|cit156","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2007-1014572","article-title":"High dose tranylcypromine therapy for refractory depression","volume":"22","author":"Amsterdam","year":"1989","journal-title":"Pharmacopsychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB157|cit157","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0006-3223(94)90888-5","article-title":"Clinical use of ketoconazole in hypocortisoluric depressives","volume":"35","author":"Ravaris","year":"1994","journal-title":"Biological Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB158|cit158","first-page":"233","article-title":"Recent aspects of biological treatment of depression","volume":"47","author":"Poldinger","year":"1990","journal-title":"Therapeutische Umschau"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB159|cit159","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial","volume":"56","author":"Stoll","year":"1999","journal-title":"Archives of General Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB160|cit160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0447.1997.tb00374.x","article-title":"Dexamethasone augmentation in treatment-resistant depression","volume":"95","author":"Dinan","year":"1997","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB161|cit161","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1176\/ajp.153.8.1112","article-title":"Dexamethasone for depression","volume":"153","author":"Wolkowitz","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB162|cit162","first-page":"59","article-title":"Omega-3 fatty acids and augmentation strategies in treating resistant depression","volume":"6","author":"Nemets","year":"2004","journal-title":"Essential Psychopharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB163|cit163","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1742-1241.2001.tb11122.x","article-title":"Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover","volume":"55","author":"Puri","year":"2001","journal-title":"International Journal of Clinical Practice"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB164|cit164","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archpsyc.59.1.91-a","article-title":"Eicosapentaenoic acid in treatment-resistant depression","volume":"59","author":"Puri","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB165|cit165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00726-001-0121-7","article-title":"Modulation of glutamate receptors: strategies for the development of novel antidepressants","volume":"23","author":"Skolnick","year":"2002","journal-title":"Amino Acids"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB166|cit166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(94)90516-9","article-title":"Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression","volume":"263","author":"Papp","year":"1994","journal-title":"European Journal of Pharmacology"},{"key":"10.1111\/j.1365-2710.2007.00846.x-BIB167|cit167","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Archives of General Psychiatry"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2007.00846.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2007.00846.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T22:22:38Z","timestamp":1685658158000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2007.00846.x"}},"subtitle":["Augmentation strategies for TRD"],"short-title":[],"issued":{"date-parts":[[2007,9,14]]},"references-count":167,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2007.00846.x","relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,14]]}}}